A Phase 2, Parallel Group, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Multicenter Treatment Study to Evaluate the Efficacy and Safety of GSK4527226 [AL101] Intravenous Infusion Compared with Placebo in Patients with Early Alzheimer’s Disease

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date29/02/24 → 27/02/26

Keywords

  • Clinical Trials
  • 219867
  • GSK4527226